Two Arizona bio startups earn $100K through Flinn entrepreneurship program
The application to select the next cohort of participants will open in 2026. More details to be announced.
Program Eligibility
To be eligible for the program, an entity must be an Arizona-based bioscience company engaged in the commercialization of bioscience research and biotechnology in the areas of:
- Medical devices and equipment;
- Medical technologies;
- Drugs, pharmaceuticals and diagnostics;
- Agricultural feedstock and chemicals; or
- Research, testing and medical labs.
The company must be incorporated as an S-Corp, LLC, or C-Corp, and based in Arizona and in pre- or early-revenue stage. Research-only projects do not qualify.
Past Flinn Foundation Bioscience Entrepreneurship Program participants and Flinn Foundation Translational Seed Grants Program awardees are eligible to apply.
Application Requirements
Up to two Arizona-based startups receive up to $100,000 in non-dilutive funding, plus support and connections.
The application consists of a basic application form and three attachments:
Review Process
A two-phase review process was utilized for the 2025 program.
Phase 1 is an application review of the submitted documents by cross-disciplinary teams with expertise in business, tech transfer, and health.
Phase 2 is an in-person interview for 10 finalists with industry and scientific experts. Up to two startups are competitively selected for funding.
All applicants receive a summary of reviewer feedback.
Learn more
Program benefits and background
Meet the program participants from 2014 to today
Questions
If you have any questions about the program or application process, please contact Joanna Yang Yowler, Ph.D., Flinn Foundation Program Manager, Translational Biosciences and Entrepreneurship.
